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This study was designed to determine the ancestral composition of a multi-ethnic sample collected for studies of
drug addictions in New York City and Las Vegas, and to examine the reliability of self-identified ethnicity and
three-generation family history data. Ancestry biographical scores for seven clusters corresponding to world major
geographical regions were obtained using STRUCTURE, based on genotypes of 168 ancestry informative markers
(AIMs), for a sample of 1,291 African Americans (AA), European Americans (EA), and Hispanic Americans (HA) along
with data from 1,051 HGDP-CEPH ‘diversity panel’ as a reference. Self-identified ethnicity and family history data,
obtained in an interview, were accurate in identifying the individual major ancestry in the AA and the EA samples
(approximately 99% and 95%, respectively) but were not useful for the HA sample and could not predict the extent
of admixture in any group. The mean proportions of the combined clusters corresponding to European and Middle
Eastern populations in the AA sample, revealed by AIMs analysis, were 0.13. The HA subjects, predominantly Puerto
Ricans, showed a highly variable hybrid contribution pattern of clusters corresponding to Europe (0.27), Middle East
(0.27), Africa (0.20), and Central Asia (0.14). The effect of admixture on allele frequencies is demonstrated for two
single-nucleotide polymorphisms (118A>G, 17 C> T) of the mu opioid receptor gene (OPRM1). This study
reiterates the importance of AIMs in defining ancestry, especially in admixed populations.
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The well-established genetic differences between ancestral
populations may have an effect on disease prevalence and
outcomes, as well as on drug response [1]. The presence
of subgroups that differ in allele frequencies is relevant to
public health and has numerous clinical implications.
Analysis of population structure using a clustering algo-
rithm can distinguish between populations based on DNA
polymorphisms [1]. Admixture occurs when a new hybrid
population is formed from formerly isolated populations
[2]. Estimating the proportions of different ancestries in
admixed populations is especially important in case–
control association studies, since spurious associations
may occur due to population substructure [3,4]. To avoid
spurious associations, researchers can adjust the regression* Correspondence: levrano@rockefeller.edu
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reproduction in any medium, provided the ormodel in an association study for individual admixture by
estimating individual ancestry with a set of ancestry in-
formative markers (AIMs) that have high allele frequency
differences between continental groups.
African and Hispanic Americans constitute a large
part of the US population (approximately 12% each).
The majority of the African American (AA) population
is a recently admixed population (average of approxi-
mately six generations, >200 years ago) generated pri-
marily by forced migration from Africa and a diverse
range of admixture with European Americans (EA) and
Native Americans (NA).
The term Hispanics/Latinos refers to a diverse popula-
tion of Latin American descent. The Hispanic/Latino
complex genetic structure reflects over five centuries of
historical confluence of three major parental populations:
Native American, European (primarily from the Iberian
Peninsula and Southern Europe), and West African popu-
lations, with very large variations in ancestry proportionsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Several studies have reported the admixture of this
population [e.g., 5-14]. The Hispanic subgroups in the
USA were shown to differ in the prevalence of several
diseases compared with African and European Americans.
Admixture analysis may show whether genetics explains
these differences and may allow discriminating between
socio-demographic and genetic contribution.
This study was designed to determine the ancestry
proportions of a large multi-ethnic sample, recruited for
studies of drug addiction in the USA, with a set of 168
AIMs and to examine the concordance of self-reported
ethnicities and family history with AIMs data.Materials and methods
Sample
The sample of 1,291 subjects is part of a larger cohort
that was recruited for genetic study of drug addiction in
the Laboratory of the Biology of Addictive Diseases at
The Rockefeller University, New York. This set included
only subjects who self-reported to be AA, EA, or Hispanic
American (HA), which are the major groups in our cohort.
Subjects were recruited at The Rockefeller University
Hospital, The Weill Medical College of Cornell University,
New York, The Manhattan Campus of the VA NY Harbor
Health Care System, and the Dr. Miriam and Sheldon G.
Adelson Clinic for Drug Abuse Treatment and Research,
Las Vegas. They included former opiate addicts in metha-
done maintenance treatment (n=726), cocaine and/or al-
cohol addicts (n= 143), and healthy volunteers (n= 422).
A subset of this sample (e.g., EA and AA opiate addicts
and healthy volunteers) was included in our previously
reported case–control association studies [15,16].
Subjects completed a three-generation family history
questionnaire developed in our laboratory as part of
their ascertainment interview. The family history ques-
tionnaire includes questions on (1) place of birth (i.e.,
city, state, country, and region); (2) self-identified race,
ethnicity, or cultural group; and (3) nationality. Each
question was answered for self, parents, grandparents,
and great-grandparents, when known. The question-
naire was filled in by an experienced clinician inter-
viewer. No pre-set list of categories was provided.
Responses were assigned into nine categories: African,
AA, EA, HA, Asian, Caribbean African, NA, Other/
Mixed, and Unknown. Ambiguous responses were
assigned by the authors based on geographical regions.
All subjects signed an informed consent for genetic
studies with a 99.7% consent rate [17]. The institutional
review boards of The Rockefeller University, VA NY,
and Cornell University approved the study. The Rockefeller
University IRB also reviews the Adelson Clinic, Las
Vegas.DNA preparation and genotyping
DNA was extracted from blood using the standard
salting-out method. Two hundred and fifty to five hun-
dred ng DNA was used for genotyping, as described
[16]. Genotyping of AIMs and OPRM1 single-nucleotide
polymorphisms (SNPs) was performed on a 1,536-plex
GoldenGate™ Custom Panel (Illumina, San Diego, CA,
USA) [18]. Genotyping was performed at The Rockefel-
ler University Genomics Resource Center according to
the manufacturer's protocol (Illumina). Analysis was per-
formed using BeadStudio genotyping software (Illumina).
Genotype data were filtered based on SNP call rates
(>99.5%) and cluster separation, and 18 AIMs were
excluded from the analysis because of poor cluster sep-
aration (Additional file 1: Table S1). Random samples
(approximately 10%) were genotyped in duplicate with
high reproducibility rate (99.9%).
Determination of individual ancestry by AIMs
The set of 186 unlinked AIMs was selected based on
differences in allele frequency by at least 70% and 10-
fold between at least two continental populations (from
among European, African, and Asian populations of the
HapMap project) (Additional file 1: Table S1) [19].
Genotypes of 168 AIMs with adequate quality were ana-
lyzed using STRUCTURE v.2.2 software [20] to obtain
individual ancestry proportions (ancestry biographical
score). Analysis was also performed for a known set
of 1,051 subjects representing 51 worldwide populations
(the Cell Line Panel of the Human Genome Diversity Pro-
ject (HGDP)/Centre d’Etude du Polymorphisme Humain
(CEPH)) [21].
The number of clusters (K) was defined by running
the data with different K values and computing the prob-
ability of K= n in the HGDP sample. The seven-factor
solution was optimal and closely replicated the seven-
factor solution found for the same 51 reference popula-
tions that matched major geographical regions [1,22].
In the current analysis, the entire sample was analyzed
simultaneously with the reference set in an ‘anchored’
approach that was shown to yield a stable factor struc-
ture interpretable in the context of worldwide genetic di-
versity [22-24]. An ancestry biographical score for seven
clusters corresponding to geographical regions: Africa,
Europe, Middle East, Central Asia, Far East Asia, Oceania
(islands of the tropical Pacific Ocean), and America, was
estimated for each individual, with reference to the 1,051
individual panel, and sum to 1 [22].
Results
A set of 1,291 subjects was selected for this study based
on self-report ethnicity. This set is part of a larger cohort
that was recruited for genetic study of drug addiction
from New York City and Las Vegas. The subjects belong
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(n= 563), and HA (n= 293). Ancestry biographical scores
for seven clusters (K) were obtained for each subject
using STRUCTURE analysis of 168 AIMs. The analysis
was performed for each sample along with 1,051 HGDP
samples as a reference (see the ‘Materials and methods’
section). Based on the HGDP sample, the seven factors
correspond to the geographical regions of Africa, Europe,
Middle East, Central Asia, Far East Asia, Oceania, and
America, and they are named by the geographical regions
hereafter, for simplicity. Figure 1a shows the relative
ancestry contributions for each subject in each of the
three groups. There is a very small contribution of
clusters corresponding to Oceania and Far East Asia in
this sample.African Americans
Complete or almost complete (>10/14 possible answers)
three-generation family history was available for 296
subjects (68%). Partial information was available for 87
subjects (20%), and no family data were available for 52
subjects including 3 adopted subjects (12%). Based on
this data, the AA group can be divided into the follow-
ing subgroups: AA for at least two generations with no
report of another ancestry (41%), AA with some Carib-
bean ancestry, African Caribbean, AA with some Native
American ancestry, AA with some European ancestry,
mixed ancestry, new immigrants from Africa, and un-
known ancestry (Table 1).
Based on AIMs analysis, the major ancestry contribu-
tion for the majority (96%) of the self-identified AA sub-
jects is African, as is shown in Figure 1a. The second
major contribution (0.26–0.40) is from Europe, Middle
East, or Central Asia. The mean proportions of each of
the major factors in the AA sample are shown in Table 1.
The mean African contribution for the subgroups that
were divided based on family history data was 0.80 for
the subgroups of African Americans, African Caribbeans,
some Caribbean ancestry, and some Native American
ancestry. AIMs analysis detected a lower mean African
contribution (0.70) in the sample that reported some
European ancestry or mixed ancestry and a higher mean
African contribution (0.94) in new immigrants from Africa,
as expected, validating the sensitivity of this set of AIMs.
Notably, there was a very small Native American contribu-
tion in all subgroups including those (n=59) that reported
some Native American ancestry.
Comparison between self-identification and AIMs data
revealed 17 subjects for whom the contribution of the
African factor was less than 50%. There were 13 sub-
jects (3%) with an African contribution in the 0.25–0.5
range for which the other major contributing factor was
European, Middle East, or Central Asia. There were foursubjects (0.9%) with a <0.25 African contribution, but
none of them had family history data.
Hispanic Americans
Complete or almost complete three-generation family
history was available for 202 subjects (71%). Partial in-
formation was available for 53 subjects (18%), and no
family data were available for 32 subjects (11%) includ-
ing 1 adopted subject. Based on the three-generation
family history data, the self-identified HA subjects can be
divided to the following subgroups: Puerto Ricans (62%),
mixed or other Caribbean Islands, Latin Americans,
Caribbean/Latin Americans, Puerto Ricans with European
ancestry, and no data (Table 1).
Based on AIMs analysis, the distribution of individual
admixture estimates in the HA sample show a wide
range of ancestry proportions (Figure 1a). Of the 293
self-reported HA, 150 subjects (51%) have a hybrid pat-
tern of five ancestries (all with frequency <0.5), 52 sub-
jects (18%) have major European ancestry, 53 (18%)
subjects have a major Middle Eastern contribution, 22
subjects (8%) have a major African ancestry contribu-
tion, 13 subjects (4%) have a major Central Asian contri-
bution, and 3 subjects (1%) have a major Native
American contribution (Figure 1b). The mean propor-
tions of each of the five major clusters are listed in
Table 1. It is clear that the reported family history does
not reflect the complex ancestry contribution indicated
by analysis of AIMs. Although the mean contributions
from Far East Asia and Oceania were low (<0.02), 33
subjects have a >0.05 contribution from Oceania and 24
subjects show a >0.05 contribution from Far East Asia.
There is a higher contribution of Native American in the
Latin American subgroup (0.19) and the mixed Caribbean/
Latin American subgroup (0.13) compared to other sub-
groups supporting the sensitivity of this set of AIMs.
European Americans
AIMs analysis of the 563 self-reported European
Americans showed that the major ancestry contribution
was as follows (Figure 1a): 494 subjects (88%) have
major European ancestry (>0.50), 33 (6%) subjects have
a major Middle Eastern contribution, 12 (2%) subjects
have a major Central Asian contribution, 4 (<1%) sub-
jects have a major African contribution, 18 (3%) subjects
have mixed contributions from Europe, Middle East, and
Central Asia, and 2 subjects (<1%) show mixed contri-
butions from Europe, Middle East, and Native America.
The mean proportions of the major factors are shown in
Table 1.
The comparison between family ancestry and AIMs in
this group is beyond the scope of this study, as the spe-
cific AIMs were designed for continental populations
and are of limited use in detecting substructure in
Figure 1 Individual admixture estimates and the distribution of the major ancestry contributions in the HA group. (a) Schematic
representation of the individual admixture estimates using (K= 7). Each vertical line represents one individual, and subjects are displayed
according to their predominant cluster contribution. The clusters correspond to the geographical regions based on the HGDP sample. Color
code: Africa (blue), Europe (red), Middle East (purple), Central Asia (yellow), Far East Asia (cyan), Oceania (amber), and America (green). (b) The
distribution of the major ancestry contributions (frequency> 0.5) in the HA group. Color code: no single major ancestry (gray); major ancestries:
Europe (red), Middle East (purple), Africa (blue), Central Asia (yellow), and America (green).
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However, to identify potential conflicts between AIMs
data and self-identified ethnicity, analysis of the family
history data was performed for 34 subjects with a low
European ancestry contribution indicated by AIMs ana-
lysis (<0.25). No family data were available for six sub-
jects, including one adopted subject. As is shown in
Table 2, out of the 18 subjects in which the majorcontribution indicated by AIMs analysis was from the
Middle East, 6 subjects were Jewish (2 of them reported
some non-European ancestry), 8 subjects were from
Italy, Malta, Greece, or Iran, and 4 have no data avail-
able. We have recently showed a high contribution of
the Middle East cluster in Israeli non-Ashkenazi Jewish
subjects using the same set of AIMs [25]. The one sub-
ject, in whom a large Native American contribution was
Table 1 Self-identification, family history, and ancestry biographical score based on AIMs
Self-identified Family history data n Clusters (K)a
1 2 3 4 5
Africa Europe Middle East Central Asia America
African Americans
African American 179 0.83 0.05 0.05 0.05 0.01
Some Caribbean ancestry 32 0.79 0.07 0.05 0.05 0.01
African Caribbean 40 0.82 0.05 0.05 0.05 <0.01
Some Native American ancestry 59 0.79 0.07 0.06 0.05 0.02
Some European ancestry 17 0.70 0.10 0.12 0.05 <0.01
Mixed ancestry 48 0.72 0.06 0.08 0.06 <0.01
New immigrants from Africa 8 0.94 0.01 0.02 0.01 <0.01
No family data 52 0.74 0.09 0.07 0.08 <0.01
Total 435 0.80 0.07 0.06 0.05 0.01
(SD) (0.12) (0.08) (0.07) (0.05) (0.01)
Hispanic Americans
Puerto Rican 181 0.18 0.27 0.30 0.14 0.07
Other Caribbean or mixed Caribbean 35 0.35 0.27 0.20 0.11 0.04
Latin American 22 0.20 0.20 0.19 0.17 0.19
Caribbean/Latin American 6 0.09 0.27 0.31 0.16 0.13
Puerto Rican with some European ancestry 15 0.19 0.33 0.26 0.14 0.05
No data 34 0.17 0.30 0.24 0.17 0.09
Total 293 0.20 0.27 0.27 0.14 0.08
(SD) (0.18) (0.22) (0.24) (0.16) (0.11)
European Americans
Total 563 0.01 0.81 0.10 0.06 0.01
(SD) (0.01) (0.17) (0.13) (0.08) (0.01)
aData for the clusters corresponding to Oceania and Far East Asia are not presented (<0.02). SD standard deviation.
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ancestry. We found no support in the family history for
the subjects in whom a major Central Asian (n = 9) or
African contribution (n = 2) was indicated by AIMs.Table 2 Family ancestry data in European Americans with
<0.25 European ancestry
Major ancestry (AIMs) n Family history n
Middle East 18 Jewish 6
Italy, Malta, Greece 7
Iran 1
No data 4
Mixed Native American/Middle East 1 Latin America 1
Central Asia 10 Adopted 1
Europe 7
No data 2
Africa 4 Europe 2
No data 2
Middle East/Central Asia 1 Europe 1
Total 34 34Allele frequencies of mu opioid receptor (OPRM1) SNPs in
HA
To illustrate a situation of population-specific allele fre-
quencies and their potential effect in admixed popula-
tions, allele and genotype frequencies were calculated
for two missense polymorphisms (118A>G (rs1799971)
and 17C>T (rs1799972)) in the OPRM1 gene that plays
an important role in opioid addiction [26]. Data from
dbSNP, HapMap, and ALFRED show that the 118 G al-
lele is common in Asians and Amerindians/Native
Americans (0.35–0.5), is rare in African and Oceania
populations, and occurs in moderate frequencies in
European and Mexican populations (0.15–2.0). The
17C>T was not genotyped in the HapMap or AL-
FRED projects, but other studies and unpublished data
from our laboratory indicate that it is African-specific
(0.2–0.3) [27,28].
Analysis of genotype data from this study sample
shows that the 17 T allele is rare in EA and HA (0.06)
and its frequency in the AA group is 23%, in concord-
ance with data from other studies (Table 3). The 118 G
allele is rare in the AA group and has a frequency of
Table 3 Allele frequencies of OPRM1 SNPs
Self-described 17 C> T (rs1799972) 118A>G (rs1799971)
C T A G
EA 0.98 0.02 0.88 0.12
AA 0.77 0.23 0.97 0.03
HA 0.94 0.06 0.82 0.17
EA vs. HA p< 0.004.
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data demonstrate that all the carriers of the 118 G allele
have some European, Asian, and/or Native American
contribution that could explain its origin. The frequen-
cies of the 17 T and 118 G alleles and their related geno-
types in the HA sample were significantly higher than
those of European Americans (17% vs. 12%, and 6% vs.
2%, respectively, p< 0.004 for chi-squared test) (Table 3).
This difference can be explained by the contribution of
African and Asian ancestries. Since the contributions of
different ancestries vary between different HA samples,
the frequencies of the 118 G and 17 T alleles found in
this sample may not represent the frequency in other
HA samples.
Discussion
In this study, we have used a panel of 168 AIMs to esti-
mate the ancestry composition of a multi-ethnic US
sample collected for studies of drug addictions in New
York City and Las Vegas. We compared this information
to self-identified ethnicity and family history data. This
comparison revealed high concordance in the major an-
cestry between self-identified ethnicity and AIMs ana-
lysis in African Americans and European Americans in
agreement with other studies [10,29-31]. However, self-
identified ethnicity and family history data could not
predict the degree of admixture that may have an effect
on allele frequencies.
This study reiterates the complexity of the ‘Hispanic/
Latino’ term. Our results are compatible with studies in-
dicating a relatively high European contribution (>50%)
in subgroups of this population [5,7-9,12-14]. The study
emphasizes the importance of AIMs data in genetic
studies of HA since the self-identified ethnicity and family
history may not reveal the complex ancestry contributions
of this group. A special scrutiny has to be used in case–
control association studies in this population, and AIMs
data should be used to correct for potential population
stratification.
The major Hispanic subgroup in this study was Puerto
Rican, a population that currently represents approxi-
mately 1.5% of the US population. The pattern of ances-
tral proportions may have clinical significance for
specific diseases when a specific ancestry may have a
protective effect based on alleles with higher frequencyin this population. For example, a recent study of end-
stage kidney disease in Hispanics from New York City
reported an approximately 30% African contribution and
a very small Native American contribution [9] emphasiz-
ing the difference between ‘Mexican Hispanics’ and
‘Caribbean Hispanics.’ The sample in the current study
was collected in Las Vegas and New York City and has
a small, unrepresentative proportion of Hispanics of
Mexican origin; conversely, studies with a mix HA from
the East, the South West, and the West coasts of the
USA are expected to have even larger level of admixture.
This study confirmed the finding of other studies
showing a highly diverse proportion of European ances-
try in self-identified AAs (7–21%) [9,22,23,30,32,33].
This diversity can be explained in part by the historical
‘one-drop rule’ (which classified individuals with any
level of African ancestry as ‘African Americans’). It is
clear that for the AA population, self-identified ethnicity
is not sufficient to estimate the admixture level and a
random AA sample may differ in admixture level from
another sample, to an extent that will affect allele fre-
quencies. The average of 7% of European admixture in
this sample is compatible with some studies [22-24,33]
but is lower than other studies [30,32,34,35]. This differ-
ence may be explained in part by the various numbers of
defined clusters used in the different studies. Our
STRUCTURE analysis was based on seven clusters, and
the European cluster obtained in studies based on small
number of clusters is most probably represented in our
study by two clusters: Europe and Middle East. These
clusters were found to be relatively close (population dif-
ferentiation index Fst = 0.005) [36] and the Middle East
cluster was shown to form a gradient across Europe
[37]. Including the Middle East cluster in the total Euro-
pean contribution would result in a 13% contribution
that is closer to the estimate by other studies. The differ-
ence between our estimates of ancestral proportions and
other studies may also reflect recruitment from different
US regions and the use of a different set of AIMs.
Our finding of a very low Native American contribu-
tion in this AA sample, based on AIMs analysis, is com-
patible with other studies [9,22,32] and may represent a
conflict with some of the reported family history. It is
also possible that this sample does not represent other
AA groups in the USA. It most likely does not reflect a
limitation in the AIMs set or the analysis since this clus-
ter was clearly detected in HA.
In this study, we have shown the effect of admixture
on allele frequencies of two SNPs in the mu opioid re-
ceptor gene, OPRM1 (118A>G and 17C>T). The sig-
nificantly higher frequency of the 118 G allele in this
small random HA sample compared with the EA sample
probably reflects the contribution of Asian and Native
American ancestries. Similarly, the significantly higher
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with the EA sample most probably reflects the contribu-
tion of African ancestry. This study reiterates the im-
portance of AIMs in defining ancestry, especially in
admixed populations and emphasizes the concept that
Hispanic Americans is not a valid category in genetic
research.
This study provides support for the robustness of this
set of AIMs, as our results corroborate the results of
other studies using this set [18,22-24]. The study demon-
strates that computation of ethnic factor scores ‘anchored’
against worldwide genetic diversity (CEPH reference
populations) yields a stable factor structure, allows com-
parisons between different datasets, and may permit
combining data from different studies. This set of AIMs
is especially useful in situations where large-scale geno-
typing is not available.
There are several limitations to this study: first, our sam-
ple does not represent the general US population, as it
was derived from only two main locales (Las Vegas and
New York City), with unrepresentative low proportion of
Mexican Americans. Second, the specific AIMs used in
this study were selected based on HapMap data (release
#16c.1, 2005) [19] and as such are limited to allele fre-
quency data from small samples of three main original
HapMap populations (Northern and Western Europe
(CEPH), Nigeria (Yoruba), and Han Chinese (Beijing)) and
may not be suited for analysis of certain populations.
Albeit very promising, great care must be used in re-
search of this kind to avoid misleading interpretations.
Genetic ancestry estimates could help the dismissal of
the concept of race, but may also support the notion of
distinct human biological subgroups that may increase
stigmatization and discrimination [38,39]. There is grow-
ing evidence that major health differences between
populations involve gene-environment interaction, and,
as such, their understanding will need not only genetic
tools but also social/cultural information [22].
Additional files
Additional file 1: Table S1. List of AIMs.
Competing interests
The authors declare that they have no competing interests.
Acknowledgments
We thank all the clinical staff including John Rotrosen, Paul Casadonte (VA
New York Harbor Healthcare System), Shirley Linzy (The Adelson Clinic, LV),
Lisa Borg, Brenda Ray, Elizabeth Ducat, and Dorothy Melia (The Rockefeller
University) for patient recruitment and ascertainment; David Goldman and
the Laboratory of Neurogenetics (NIAAA) for assistance with STRUCTURE
analysis; Matthew Randesi, Connie Zhao, and Bin Zhang for technical
assistance; and Susan Russo for proofreading the manuscript. This work was
supported by the National Institutes of Health - National Institute of Drug
Addiction [P60-05130 to MJK] and the Adelson Medical Research
Foundation.Author details
1The Laboratory of the Biology of Addictive Diseases, The Rockefeller
University, New York NY10065, USA. 2Laboratory of Neurogenetics, National
Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA. 3The
Dr. Miriam and Sheldon G. Adelson Clinic for Drug Abuse Treatment and
Research, Las Vegas, NV 89169, USA.Authors’ contributions
OL designed the study, carried out the genetic studies, performed data
analysis and interpretation, and wrote and revised the manuscript. OA
performed data analysis and interpretation. PHS performed STRUCTURE
analysis. MA supervised subject recruitment, and ascertainment and
acquisition of ancestry data of the LV sample. MJK supervised the overall
subject recruitment, ascertainment and acquisition of ancestry data, and
critically reviewed the manuscript. All authors read and approved the final
manuscript.
Received: 1 September 2011 Accepted: 5 July 2012
Published: 5 July 2012References
1. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA,
Feldman MW: Genetic structure of human populations. Science 2002,
298:2381–2385.
2. Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, Boehnke M:
Genome-wide association studies in diverse populations. Nat Rev Genet
2010, 11:356–366.
3. Tian C, Gregersen PK, Seldin MF: Accounting for ancestry: population
substructure and genome-wide association studies. Hum Mol Genet 2008,
17:R143–R150.
4. Cardon LR, Palmer LJ: Population stratification and spurious allelic
association. Lancet 2003, 361:598–604.
5. Peralta CA, Li Y, Wassel C, Choudhry S, Palmas W, Seldin MF, Risch N,
Siscovick D, Arnett D, Psaty B, Shlipak MG: Differences in albuminuria
between Hispanics and whites: an evaluation by genetic ancestry and
country of origin: the multi-ethnic study of atherosclerosis. Circ
Cardiovasc Genet 2010, 3:240–247.
6. Ruano G, Duconge J, Windemuth A, Cadilla CL, Kocherla M, Villagra D, Renta
J, Holford T, Santiago-Borrero PJ: Physiogenomic analysis of the Puerto
Rican population. Pharmacogenomics 2009, 10:565–577.
7. Bonilla C, Shriver MD, Parra EJ, Jones A, Fernández JR: Ancestral
proportions and their association with skin pigmentation and bone
mineral density in Puerto Rican women from New York city. Hum Genet
2004, 115:57–68.
8. Bryc K, Velez C, Karafet T, Moreno-Estrada A, Reynolds A, Auton A, Hammer
M, Bustamante CD, Ostrer H: Colloquium paper: genome-wide patterns of
population structure and admixture among Hispanic/Latino populations.
Proc Natl Acad Sci USA 2010, 107(Suppl 2):8954–8961.
9. Behar DM, Rosset S, Tzur S, Selig S, Yudkovsky G, Bercovici S, Kopp JV,
Winkler CA, Nelson GW, Wasser WG, Skorecki K: African ancestry allelic
variation at the MYH9 gene contributes to increased susceptibility to
non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol
Genet 2010, 19:1816–1827.
10. Divers J, Redden DT, Rice KM, Vaughan LK, Padilla MA, Allison DB, Bluemke
DA, Young HJ, Arnett DK: Comparing self-reported ethnicity to genetic
background measures in the context of the Multi-Ethnic Study of
Atherosclerosis (MESA). BMC Genet 2011, 12:28.
11. Wang S, Ray N, Rojas W, Parra MV, Bedoya G, Gallo C, Poletti G, Mazzotti G,
Hill K, Hurtado AM, Camrena B, Nicolini H, Klitz W, Barrantes R, Molina JA,
Freimer NB, Bortolini MC, Salzano FM, Petzl-Erler ML, Tsuneto LT, Dipierri JE,
Alfaro EL, Bailliet G, Bianchi NO, Llop E, Rothhammer F, Excoffier L, Ruiz-
Linares A: Geographic patterns of genome admixture in Latin American
Mestizos. PLoS Genet 2008, 4:e1000037.
12. Choudhry S, Burchard EG, Borrell LN, Tang H, Gomez I, Naqvi M, Nazario S,
Torres A, Casal J, Martinez-Cruzado JC, Ziv E, Avila PC, Rodriguez-Cintron W,
Risch NJ: Ancestry-environment interactions and asthma risk among
Puerto Ricans. Am J Respir Crit Care Med 2006, 174:1088–1093.
13. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, Clark SL, Tsai HJ, Naqvi M,
Phong A, Ung N, Matallana H, Avila PC, Casal J, Torres A, Nazario S, Castro R,
Battle NC, Perez-Stable EJ, Kwok PY, Sheppard D, Shriver MD, Rodriguez-
Levran et al. Human Genomics 2012, 6:2 Page 8 of 8
http://www.humgenomics.com/content/6/1/2Cintron W, Risch N, Ziv E, Burchard EG: Population stratification confounds
genetic association studies among Latinos. Hum Genet 2006, 118:652–664.
14. Via M, Gignoux CR, Roth LA, Fejerman L, Galanter J, Choudhry S, Toro-
Labrador G, Viera-Vera J, Oleksyk TK, Beckman K, Ziv E, Risch N, Burchard EG,
Martínez-Cruzado JC: History shaped the geographic distribution of
genomic admixture on the island of Puerto Rico. PLoS One 2011, 6:e16513.
15. Levran O, Londono D, O'Hara K, Randesi M, Rotrosen J, Casadonte P, Linzy S,
Ott J, Adelson M, Kreek MJ: Heroin addiction in African Americans: a
hypothesis-driven association study. Genes Brain Behav 2009, 8:531–540.
16. Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J, Casadonte
P, Linzy S, Randesi M, Ott J, Adelson M, Kreek MJ: Genetic susceptibility to
heroin addiction: a candidate gene association study. Genes Brain Behav
2008, 7:720–729.
17. Ray B, Jackson C, Ducat E, Ho A, Hamon S, Kreek MJ: Effect of ethnicity,
gender and drug use history on achieving high rates of affirmative
informed consent for genetics research: impact of sharing with a
national repository. J Med Ethics 2011, 37:374–379.
18. Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA, Binder EB,
Cubells J, Ehlers CL, Gelernter J, Mann J, Riley B, Roy A, Tabakoff B, Todd RD,
Zhou Z, Goldman D: Addictions biology: haplotype-based analysis for 130
candidate genes on a single array. Alcohol Alcohol 2008, 43:505–515.
19. Enoch MA, Shen PH, Xu K, Hodgkinson C, Goldman D: Using ancestry-
informative markers to define populations and detect population
stratification. J Psychopharmacol 2006, 20:19–26.
20. Pritchard JK, Stephens M, Donnelly P: Inference of population structure
using multilocus genotype data. Genetics 2000, 155:945–959.
21. Cann HM, de Toma C, Cazes L, Legrand MF, Morel V, Piouffre L, Bodmer J,
Bodmer WF, Bonne-Tamir B, Cambon-Thomsen A, Chen Z, Chu J, Carcassi C,
Contu L, Du R, Excoffier L, Ferrara GB, Friedlaender JS, Groot H, Gurwitz D,
Jenkins T, Herrera RJ, Huang X, Kidd J, Kidd KK, Langaney A, Lin AA, Mehdi
SQ, Parham P, Piazza A, et al: A human genome diversity cell line panel.
Science 2002, 296:261–262.
22. Ducci F, Roy A, Shen PH, Yuan Q, Yuan NP, Hodgkinson CA, Goldman LR,
Goldman D: Association of substance use disorders with childhood
trauma but not African genetic heritage in an African American cohort.
Am J Psychiatry 2009, 166:1031–1040.
23. Liu J, Zhou Z, Hodgkinson CA, Yuan Q, Shen PH, Mulligan CJ, Wang A, Gray
RR, Roy A, Virkkunen M, Goldman D, Enoch MA: Haplotype-based study of
the association of alcohol-metabolizing genes with alcohol dependence
in four independent populations. Alcohol Clin Exp Res 2011, 35:304–316.
24. Enoch MA, Gorodetsky E, Hodgkinson C, Roy A, Goldman D: Functional
genetic variants that increase synaptic serotonin and 5-HT3 receptor
sensitivity predict alcohol and drug dependence. Mol Psychiatry 2011,
16:1139–1146.
25. Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ: CYP2B6 SNPs
are associated with methadone dose required for effective treatment of
opioid addiction. Addict Biol 2011, doi:10.1111/j.1369-1600.2011.00349.x.
26. Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA: Pharmacogenetics and
human molecular genetics of opiate and cocaine addictions and their
treatments. Pharmacol Rev 2005, 57:1–26.
27. Crystal HA, Hamon S, Randesi M, Cook J, Anastos K, Lazar J, Liu C, Pearce L,
Golub E, Valcour V, Weber KM, Holman S, Ho A, Kreek MJ: A C17T
polymorphism in the mu opiate receptor is associated with quantitative
measures of drug use in African American women. Addict Biol 2012,
17:181–191.
28. Gelernter J, Kranzler H, Cubells J: Genetics of two mu opioid receptor
gene (OPRM1) exon I polymorphisms: population studies, and allele
frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry
1999, 4:476–483.
29. Dumitrescu L, Ritchie MD, Brown-Gentry K, Pulley JM, Basford M, Denny JC,
Oksenberg JR, Roden DM, Haines JL, Crawford DC: Assessing the accuracy
of observer-reported ancestry in a biorepository linked to electronic
medical records. Genet Med 2010, 12:648–650.
30. Yaeger R, Avila-Bront A, Abdul K, Nolan PC, Grann VR, Birchette MG,
Choudhry S, Burcahrd EG, Beckman KB, Gorroochurn P, Ziv E, Consedine NS,
Joe AK: Comparing genetic ancestry and self-described race in african
americans born in the United States and in Africa. Cancer Epidemiol
Biomarkers Prev 2008, 17:1329–1338.
31. Lee YL, Teitelbaum S, Wolff MS, Wetmur JG, Chen J: Comparing genetic
ancestry and self-reported race/ethnicity in a multiethnic population in
New York City. J Genet 2010, 89:417–423.32. Reiner AP, Ziv E, Lind DL, Nievergelt CM, Schork NJ, Cummings SR, Phong A,
Burchard EG, Harris TB, Psaty BM, Kwok PY: Population structure,
admixture, and aging-related phenotypes in African American adults:
the Cardiovascular Health Study. Am J Hum Genet 2005, 76:463–477.
33. Bensen JT, Xu Z, Smith GJ, Mohler JL, Fontham ET, Taylor JA: Genetic
polymorphism and prostate cancer aggressiveness: a case-only study of
1,536 GWAS and candidate SNPs in African-Americans and European-
Americans. Prostate 2012. doi:10.1002/pros.22532.
34. Fejerman L, Haiman CA, Reich D, Tandon A, Deo RC, John EM, Ingles SA,
Ambrosone CB, Bovbjerg DH, Jandorf LH, Davis W, Ciupak G, Whittemore
AS, Press MF, Ursin G, Bernstein L, Huntsman S, Henderson BE, Ziv E,
Freedman ML: An admixture scan in 1,484 African American women with
breast cancer. Cancer Epidemiol Biomarkers Prev 2009, 18:3110–3117.
35. Murray T, Beaty TH, Mathias RA, Rafaels N, Grant AV, Faruque MU, Watson
HR, Ruczinski I, Dunston GM, Barnes KC: African and non-African admixture
components in African Americans and an African Caribbean population.
Genet Epidemiol 2010, 34:561–568.
36. Tian C, Kosoy R, Nassir R, Lee A, Villoslada P, Klareskog L, Hammarström L,
Garchon HJ, Pulver AE, Ransom M, Gregersen PK, Seldin MF: European
population genetic substructure: further definition of ancestry
informative markers for distinguishing among diverse European ethnic
groups. Mol Med 2009, 15:371–383.
37. Kidd JR, Friedlaender FR, Speed WC, Pakstis AJ, De La Vega FM, Kidd KK:
Analyses of a set of 128 ancestry informative single-nucleotide
polymorphisms in a global set of 119 population samples. Investig Genet
2011, 2:1.
38. Royal CD, Novembre J, Fullerton SM, Goldstein DB, Long JC, Bamshad MJ,
Clark AG: Inferring genetic ancestry: opportunities, challenges, and
implications. Am J Hum Genet 2010, 86:661–673.
39. Caulfield T, Fullerton SM, Ali-Khan SE, Arbour L, Burchard EG, Cooper RS,
Hardy BJ, Harry S, Hyde-Lay R, Kahn J, Kittles R, Koenig BA, Lee SSJ,
Malinowski M, Ravitsky V, Sankar P, Scherer SW, Séguin B, Shickle D, Suarez-
Kurtz G, Daar AS: Race and ancestry in biomedical research: exploring the
challenges. Genome Med 2009, 1:8.
doi:10.1186/1479-7364-6-2
Cite this article as: Levran et al.: Estimating ancestral proportions in a
multi-ethnic US sample: implications for studies of admixed
populations. Human Genomics 2012 6:2.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
